Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Clinical trial NCT03435627 · COMPLETED

Trial details

NCT number: NCT03435627
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Genetic Disorder Noonan Syndrome

Start date: 2018-02-26
Primary completion: 2022-01-18
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.